Kobayashi Pharmaceutical Co., Ltd. (4967)

Name: Kobayashi Pharmaceutical Co., Ltd. (4967) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Consumer Defensive · Wall Street (USA) · Ultimo aggiornamento: 2026-10-02

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, Southeast Asia, and internationally.

Dati chiave

Capitalizzazione di mercato: JPY 528 billion
Ricavi (esercizio chiuso a 2025-12-31): JPY 165.7B
Utile netto: JPY 3.7B
Margine lordo: 51.1%
Margine netto: 2.2%

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Entrate totali	JPY 165.7B	JPY 165.6B	JPY 173.5B	JPY 166.3B	—
Utile lordo	JPY 84.7B	JPY 87.6B	JPY 96.4B	JPY 92.3B	—
Risultato Operativo (EBIT)	JPY 14.9B	JPY 24.9B	JPY 25.8B	JPY 26.7B	—
Reddito netto	JPY 3.7B	JPY 10.1B	JPY 20.3B	JPY 20.0B	—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 4967. /companies/us/4967

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.